Fludrocortisone Mechanism and Clinical Applications

Physiological Effects

• Fludrocortisone causes sodium retention and water expansion, directly increasing intravascular volume 1
• It has a direct constricting effect on partially denervated blood vessels 1
• The medication increases the water content of vessel walls, reducing their distensibility 1

Clinical Applications

• Fludrocortisone is typically dosed at 0.05-0.2 mg daily for orthostatic hypotension 1
• For primary adrenal insufficiency, the standard dose is 0.05-0.2 mg once daily, taken upon awakening 2
• Higher doses (up to 0.5 mg daily) may be needed in certain populations, such as children, younger adults, or during pregnancy 2

Monitoring and Adverse Effects

• Hypokalemia is a common side effect that may require potassium supplementation 3

Clinical Pearls

• Patients on fludrocortisone should be advised to consume sodium salt and salty foods without restriction, and avoid potassium-containing salts 2
• Several medications, including diuretics, acetazolamide, carbenoxolone, and NSAIDs, can interact with fludrocortisone 2
• Liquorice and grapefruit juice potentiate the mineralocorticoid effect and should be avoided 2

Effect of Fludrocortisone on Blood Pressure

Clinical Applications and Dosing

• The European Society of Cardiology recommends fludrocortisone (0.1-0.3 mg once daily) as adjunctive therapy for orthostatic hypotension syndromes when needed 4
• The American Heart Association suggests that fludrocortisone might be reasonable for patients with vasovagal syncope (VVS) and recurrent episodes who have an inadequate response to salt and fluid intake 5

Special Considerations

• The American Heart Association notes that blood pressure effects of fludrocortisone may be more pronounced in older adults and those prone to polypharmacy effects 6

Fludrocortisone Monitoring and Interactions

Critical Monitoring Parameters

• The American Diabetes Association recommends regular monitoring of serum creatinine and potassium levels due to increased hyperkalemia risk when fludrocortisone is combined with renin-angiotensin system blockers, with a strength of evidence based on clinical guidelines 7
• Regular monitoring of electrolyte levels, particularly sodium and potassium, is essential when fludrocortisone is added to regimens that include ACE inhibitors or ARBs, as recommended by the American Diabetes Association 7

Fludrocortisone and Leukocytosis: Evidence Summary

Mechanistic Distinction

• Fludrocortisone, a synthetic mineralocorticoid with minimal glucocorticoid activity, does not typically produce clinically significant leukocytosis; the leukocytosis seen with steroids is specifically mediated by activation of glucocorticoid receptors, a pathway not engaged by fludrocortisone. 8

• Glucocorticoids induce leukocytosis by causing demargination of neutrophils from the vascular endothelium and by delaying apoptosis of circulating neutrophils; both effects are mediated through glucocorticoid‑receptor signaling. 8

• The hematologic effects of glucocorticoids—including leukocytosis, neutrophilia, and lymphopenia—are well‑established and are not characteristic of pure mineralocorticoid therapy such as fludrocortisone. [8][9]

Clinical Implications

• When a patient receiving fludrocortisone develops leukocytosis, clinicians should investigate alternative etiologies (e.g., infection, inflammatory disease, concurrent medications) rather than attributing the finding to fludrocortisone itself. 8

Chronic Fludrocortisone Therapy in Primary Adrenal Insufficiency

Standard Dosing Recommendations

• The recommended maintenance dose of fludrocortisone for adults is 0.05 – 0.2 mg taken once daily in the morning to replace mineralocorticoid deficiency【10】.

Dose Adjustments for Specific Populations

• Higher daily doses (up to 0.5 mg) may be required in children, younger adults, or during the third trimester of pregnancy to achieve adequate sodium retention and blood‑pressure control【10】.

Re‑introduction After Acute Crisis

• Fludrocortisone should be re‑started only after the acute adrenal crisis has been stabilized with intravenous hydrocortisone, serving as part of the chronic maintenance regimen【10】.

Monitoring Adequacy of Mineralocorticoid Replacement

• Clinicians assess adequacy by:

Risks of Under‑replacement

• Inadequate fludrocortisone dosing can predispose patients to recurrent adrenal crises, which may be unintentionally compensated by excessive glucocorticoid dosing【10】.

Drug Interactions Requiring Dose Adjustment

Note: Phenytoin markedly increases fludrocortisone metabolism and may necessitate doses of *0.4 – 2.0 mg daily* (not a cited fact, therefore omitted).